SCHEMBL4849045

SCHEMBL4849045

CC(C)(C)c1ccc(C(=O)O)c(N)c1C(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.44
KDM4E B2RXH2 1/20 0.42
MAPT P10636 3/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
GLA P06280 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SRD5A2 P31213 2/20 0.39
POLB P06746 2/20 0.39
THRB P10828 1/20 0.39
MAPK1 P28482 1/20 0.39
RECQL P46063 1/20 0.39
G6PD P11413 1/20 0.39
CASP7 P55210 1/20 0.39
CASP6 P55212 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4865215 0.84 HSD17B10 (0.46) AKR1C3KDM4EMAPTGAAALDH1A1
SCHEMBL2033555 0.81 AKR1C3 (0.52) AKR1C3KDM4EMAPTGAAALDH1A1
SCHEMBL27607912 0.80 AKR1C3 (0.59) AKR1C3KDM4EMAPTGAAALDH1A1
SCHEMBL28136021 0.78 MAPT (0.46) AKR1C3KDM4EMAPTGAAALDH1A1
SCHEMBL8713885 0.76 ALDH1A1 (0.52) AKR1C3ALDH1A1MEN1KMT2ATDP1
SCHEMBL5056827 0.76 AKR1C3 (0.48) AKR1C3KDM4EMAPTGAAALDH1A1
Benzophenone SCHEMBL28222900 0.75 ALDH1A1 (0.52) MAPTGAAALDH1A1LMNAMEN1
SCHEMBL11593170 0.75 AKR1C3 (0.62) AKR1C3KDM4EMAPTGAAALDH1A1
SCHEMBL28397888 0.74 ELANE (0.43) AKR1C3KDM4EMAPTGAAALDH1A1
SCHEMBL4849052 0.73 G6PD (0.47) AKR1C3ALDH1A1LMNAKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342039-B2 Substituted indole oximes WYETH (US) 2008-03-11 US disclosed
US-20050119326-A1 Substituted aryloximes WYETH (US) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119326-A1 Substituted aryloximes IDO2, TDO2, IDO1 AKR1C3 757/4885KDM4E 594/4885MAPT 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.